Sun Yat-sen University
Clinical trials sponsored by Sun Yat-sen University, explained in plain language.
-
Cancer combo trial halted early after enrolling just 5 women
Disease control TerminatedThis study tested a combination of two drugs—toripalimab (an immunotherapy) and chidamide (a targeted therapy)—in women with advanced cervical cancer that had come back or spread. The goal was to see if the combination was safe and could shrink tumors. However, the trial was stop…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 16, 2026 12:55 UTC
-
Experimental cell therapy targets rare sarcoma in small trial
Disease control TerminatedThis study tested a new cell therapy called TAEST16001 in 8 adults with advanced soft tissue sarcoma whose tumors have a specific marker (NY-ESO-1) and tissue type (HLA-A*02:01). The goal was to see if the treatment could shrink tumors or control the disease. The trial was ended …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Lung cancer drug trial stopped early – what happened?
Disease control TerminatedThis study tested whether the drug toripalimab could help people with limited-stage small cell lung cancer stay cancer-free longer after standard chemoradiation. The trial planned to enroll 170 adults aged 18-75 whose cancer had not grown after initial treatment. However, the stu…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC